CRISPR, a pioneering genome-editing technique, technology will allow AstraZeneca to identify and validate new drug targets in preclinical models that closely resemble human disease.
Genomics has the potential to significantly improve the efficacy of drugs and develop targeted therapies.
NIH breakthrough in gene therapy for methylmalonic acidemia.
Whole-exome sequencing reveals the mutational spectrum of testicular germ cell tumours.
University of Chicago and the National Cancer Institute are addressing one of genomics’ biggest bottlenecks.